Live feed
Filing
SC 13D/A
SC 13D/A0000903423-16-001337·CRISPR Therapeutics AG
Schedule 13D ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2016-10-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,250,627
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-16-001337
- Form type
- SC 13D/A
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Nov 07, 2016
- Reporting period
- Oct 18, 2016
- Description
- Schedule 13D beneficial ownership